The Journal of Organic Chemistry
Note
Synthesis of (S)-N-Butoxycarbonyl-N-methylvaline (1R)-2-
Methyl-1-[(phenylmethoxy)carbonyl]propyl Ester 3. To a
solution of phenylmethyl (2R)-2-hydroxy-3-methylbutanoate 1 (2.0 g,
9.6 mmol), N-methyl-N-Boc-valine 2 (2.3 g, 1.05 equiv), and 4-
dimethylaminopyridine (2.35 g, 2.0 equiv) in DCM (29 mL, 0.33M) at
0 °C was added solid HATU (4.0 g, 1.1 equiv) in several small portions.
The reaction mixture was allowed to stir for 4 h before dilution with
diethyl ether (100 mL) and water (50 mL). The organic layer was
separated and the solution washed sequentially with 1 M aq HCl (100
mL), H2O (50 mL), and half-satd aq Na2CO3 solution (2 × 100 mL,
mixing the layers vigorously for 10 min). The organic layer was dried
over MgSO4, filtered, and concentrated in vacuo to afford depsipeptide 3
as a clean oil sufficiently pure for the next steps (2.83 g, 70% yield) and
immediately subjected to the NMR experiments described in the main
text. An analytical sample for complete characterization was obtained by
subjection of the product to silica gel flash column chromatography (3%
Synthesis of Amine 6. To depsipeptide 3 (440 mg, 1.05 mmol) was
added 2 mL of a solution of 4 M HCl in dioxane. The reaction was
allowed to stir overnight at room temperature before the mixture was
concentrated in vacuo. The liquid salt was taken up in Et2O (25 mL) and
washed with half-saturated aq Na2CO3 (2 × 25 mL). The aqueous layers
were back-extracted with Et2O (2 × 25 mL) and the combined organic
layers dried over MgSO4, filtered, and concentrated in vacuo to provide
amine 6 which was sufficiently pure for the next step (212 mg, 65%). 1H
NMR (400 MHz, CDCl3): 7.39−7.28 (m, 5H), 5.21 (d, 1H, J = 12.0 Hz),
5.15 (d, 1H, J = 12.0 Hz), 4.91 (d, 1H, J = 4.4 Hz), 3.01 (d, 1H, J =
6.0 Hz), 2.35 (s, 3H), 2.27 (m, 1H), 1.94 (m, 1H), 1.53 (s, 1H), 1.02−
0.92 (m, 12H). 13C NMR (100 MHz, CDCl3): 174.9, 169.5, 135.3,
128.5, 128.4, 76.9, 69.2, 66.9, 35.2, 31.5, 30.0, 19.2, 18.9, 18.6, 17.2. IR
(neat, cm−1): 2965.8, 2936.8, 2878.3, 1734.1, 1498.8, 1465.8, 1456.1,
1266.9, 1178.7, 1164.0, 1126.1, 1019.5, 749.0, 696.9. [α]25.5D: +28.2 (c =
2.15, CHCl3). HRMS (ESI-TOF) ([M + H+]): calcd for C18H28O4N
322.2013, found 322.2012.
1
EtOAc in 40−60 petroleum ether). H NMR (600 MHz, CDCl3):
Synthesis of Didepsipeptide 7. To a solution of acid 5 (500 mg,
1.5 mmol) in DCM (5 mL) at 0 °C was added Ghosez’s reagent (240 μL,
1.2 equiv). The solution was allowed to stir for 15 min before a solution
of amine 6 (480 mg, 1 equiv) and diisopropylethylamine (690 μL, 2.6
equiv) in DCM (5 mL) was added. The solution was allowed to warm to
room temperature overnight. The reaction mixture was diluted with
Et2O (50 mL), upon which N,N-dimethylisobutylamide crystallized out
of solution. The mixture was washed with 1 M aq HCl solution (25 mL),
H2O (25 mL), and half-saturated aq Na2CO3 solution (25 mL). The
organic layer was dried over MgSO4, filtered, and concentrated in vacuo
to provide a clean crude product which was further purified by flash
column chromatography (3% to 5% to 10% EtOAc/40−60 petroleum
ether) to provide didepsipeptide 7 which was homogeneous by TLC
analysis and subjected to the NMR experiments described in the main
text (404 mg, 43%). 1H NMR (600 MHz, CDCl3): (mixture of
rotamers) 7.34−7.27 (m, 5H), 5.22−3.98 (m, 4H), 3.01−2.76 (m, 6H),
2.42−2.02 (m, 4H), 1.44 (s, 9H), 1.06−0.76 (m, 24H). 13C NMR (150
MHz, CDCl3): (mixture of rotamers) 171.0, 170.8, 170.6, 170.3, 170.2,
169.8, 169.6, 169.6, 169.4, 169.2, 168.6, 156.4, 155.7, 135.4, 135.1, 128.6,
128.5, 128.4, 128.3, 80.0, 79.7, 77.5, 75.9, 75.5, 75.0, 74.9, 67.1, 66.8,
65.7, 64.9, 64.7, 63.3, 63.0, 61.7, 61.6, 31.8, 31.7, 31.0, 30.7, 30.3, 30.0,
29.9, 29.6, 29.4, 29.4, 28.6, 28.3, 28.3, 28.0, 27.7, 27.3, 27.3, 20.1, 19.9,
19.6, 19.5, 19.4, 19.3, 19.1, 19.0, 18.9, 18.9, 18.8, 18.6, 17.1, 17.0, 16.9,
16.6, 16.4. IR (neat, cm−1): 2968.1, 2935.9, 2877.3, 1738.7, 1694.1,
1668.7, 1468.4, 1390.5, 1367.3, 1238.5, 1184.3, 1147.7, 1126.5, 1020.4,
881.3, 751.9, 697.7, 665.3. [α]26.5D: −45.7 (c = 2.0, CHCl3). HRMS
(ESI-TOF) ([M + H+]): calcd for C34H55O9N2 635.3902, found
635.3905.
(mixture of rotamers) 7.37−7.28 (m, 5H), 5.18 (d, 1H, J = 12.0 Hz),
5.12 (d, 1H, J = 12.0 Hz), 4.86 (br s, 1H), 4.59 (d, 0.5H, J = 10.6 Hz),
4.28 (d, 0.5H, J = 10.6 Hz), 2.88 (s, 1.5H), 2.77 (s, 1.5H), 2.25 (br m,
1H), 2.18 (br m, 1H), 1.46 (s, 9H), 1.02−0.87 (m, 24H). 13C NMR (150
MHz, CDCl3): (mixture of rotamers) 171.0, 170.7, 169.2, 169.0, 156.3,
155.6, 135.3, 135.3, 128.5, 128.4, 128.3, 80.1, 79.8 66.9, 66.8, 64.7, 63.0,
30.6, 30.0, 28.3, 27.6, 27.4, 19.9, 19.1, 18.8, 18.8, 18.8, 17.0. IR (neat,
cm−1): 2968.9, 2935.1, 2878.2, 1740.9, 1694.5, 1455.8, 1390.2, 1366.6,
1307.4, 1258.6, 1182.8, 1146.6, 1125.4, 1024.5, 751.8, 697.1. [α]26.5
:
D
−33.3 (c = 1.28, CHCl3). HRMS (ESI-TOF) ([M + Na+]): calcd for
C23H35O6NNa 444.2356, found 444.2356.
Synthesis of (R)-N-Butoxycarbonyl-N-methylvaline (1S)-2-
Methyl-1-[(phenylmethoxy)carbonyl]propyl Ester 4. To a
solution of phenylmethyl (2S)-2-hydroxy-3-methyl-butanoate(100 mg,
0.48 mmol), N-methyl-N-Boc-valine 2 (122 mg, 1.1 equiv), and
4-dimethylaminopyridine (152 mg, 2.6 equiv) in DCM (1.5 mL, 0.33 M)
at 0 °C was added solid HATU (220 mg, 1.2 equiv) all at once. The
reaction mixture was allowed to stir for 4 h before dilution with diethyl
ether (10 mL) and water (5 mL). The organic layer was separated, and
the solution washed sequentially with 1 M aq HCl (10 mL), H2O (5
mL), and half-satd aq Na2CO3 solution (2 × 10 mL, mixing the layers
vigorously for 10 min). The organic layer was dried over MgSO4,
filtered, and concentrated in vacuo. The product was subjected to silica
gel flash column chromatography (3% EtOAc in 40−60 petroleum
1
ether) to afford depsipeptide 4 as a clean oil (158 mg, 78% yield). H
NMR (600 MHz, CDCl3): (mixture of rotamers) 7.35−7.27 (m, 5H),
5.19 (d, 1H, J = 12.6 Hz), 5.12 (d, 1H, J = 12.6 Hz), 4.85 (app. S, 1H),
4.51 (d, 0.5 H, J = 9.9 Hz), 4.20 (d, 0.5H, J = 9.9 Hz), 2.83 (s, 1.5H), 2.79
(s, 1.5H), 2.30−2.12 (m, 2H), 1.44 (s, 9H), 1.06−0.82 (m, 12H). 13C
NMR (150 MHz, CDCl3): (mixture of rotamers) 171.1, 170.6, 169.2,
156.0, 155.4, 135.3, 128.5, 128.4, 128.3, 80.2, 79.8, 77.0, 66.9, 66.8, 64.8,
63.2, 30.7, 30.5, 30.1, 28.3, 27.6, 19.8, 19.6, 18.8, 18.8, 18.8, 18.7, 17.0. IR
(neat, cm−1): 2968.3, 2926.2, 2878.1, 1741.7, 1695.2, 1455.8, 1390.0,
1366.6, 1294.3, 1258.8, 1181.4, 1145.3, 1124.7, 1024.5, 935.6, 880.6,
750.5, 697.3. [α]26.5D: −70.9 (c = 1.63, CHCl3). HRMS (ESI-TOF)
([M + Na+]): calcd for C23H35O6NNa 444.2356, found 444.2364.
Synthesis of Acid 5. To a solution of depsipeptide 3 (1.4 g, 3.3
mmol) in THF (6.5 mL, 0.5 M) was carefully added Pd/C under Ar. The
solution was then purged with H2 gas and allowed to stir under H2 (1
atm, balloon) overnight. The reaction mixture was then purged with Ar,
filtered over a pad of Celite over silica with EtOAc (100 mL), and
concentrated in vacuo to afford acid 4 which was sufficiently pure for the
next step (1.08 g, quantitative). 1H NMR (400 MHz, CDCl3): (mixture
of rotamers) 5.01 (br s, 0.66H), 4.89 (br s, 0.34H), 4.28 (d, 0.34H, J =
9.5 Hz), 4.17 (d, 0.66H, J = 10.0 Hz), 2.91 (s, 2H), 2.86 (s, 1H), 2.30 (br
m, 2H), 1.46 (s, 9H), 1.08−0.90 (br m, 12H). 13C NMR (150 MHz,
CDCl3): 173.96, 170.87, 170.65, 156.63, 155.85, 80.49, 80.33, 76.46,
66.13, 64.66, 63.49, 31.13, 30.07, 29.99, 29.95, 29.83, 28.30, 27.52, 27.45,
19.89, 19.80, 19.09, 18.87, 18.79, 17.19, 16.96, 16.88, 16.09. IR (neat,
cm−1): 2969.7, 2935.7, 2878.6, 1741.5, 1696.4, 1657.4, 1657.4, 1469.9,
1448.7, 1392.2, 1368.6, 1309.7, 1198.5, 1149.8, 1126.6, 1022.3, 752.9.
[α]26.5D: −49.0 (c = 4.03, CHCl3). HRMS (ESI-TOF) ([M + H+]):
calcd for C16H30O6N 332.2068, found 332.2066.
ASSOCIATED CONTENT
■
S
* Supporting Information
1
Full H and 13C spectra of new compounds. This material is
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We gratefully acknowledge financial support from the BP
Endowment (to S.V.L.) and the Winston Churchill Foundation
of the United States for a scholarship to D.X.H. We also thank
Dr. James Keeler and Dr. Matthew O’Brien of the Department of
Chemistry, Cambridge, for very helpful discussions regarding the
manuscript.
REFERENCES
■
(1) Al-Horani, R. A.; Desai, U. R. Tetrahedron 2012, 68, 2027−2040.
5201
dx.doi.org/10.1021/jo300734r | J. Org. Chem. 2012, 77, 5198−5202